RARE Financial Facts

See Full Income Statement

See Full Balance Sheet

Ultragenyx Pharmaceutical Inc. (RARE) Earnings

  |   Expand Research on RARE
Next EPS Date 2/10/22 *Est. EPS Growth Rate +4.4% *Last Qtr.
Average EPS % Beat Rate -15.6% Revenue Growth Rate +0.1% *Last Qtr.
Average % Move 1-Wk after EPS +4.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/2/21 Q321 -$1.08-$1.41 +$0.33$81.6M$81.55M = Details
8/2/21 Q221 -$1.81-$1.36 -$0.45$87M$85.03M = Details
5/4/21 Q121 -$2.03-$1.24 -$0.79$99.4M$77.04M = Details
2/11/21 Q420 -$0.37N/A N/A $91.54M$35.59M = Details
10/27/20 Q320 -$1.13-$1.27 +$0.14$81.5M$53.89M = Details
7/30/20 Q220 $0.41-$1.54 +$1.95$61.71M$39.12M = Details
5/6/20 Q120 -$2.05-$1.69 -$0.36$36.31M$36.58M = Details
2/13/20 Q419 -$1.62-$1.65 +$0.03$35.6M$32.15M = Details